21 May 2013
Keywords: cortex, ampalex, schizophrenia, reported, preliminary, results, first
Article | 15 June 1998
Cortex has reported preliminary results from the first six patientsenrolled in a trial of Ampalex (CX516) plus Novartis' Clozaril (clozapine) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.